Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Tianyin Pharma Hopes to Sell Azithromycin API in India

publication date: Jul 15, 2013
Tianyin Pharma is looking for deals to market its Azithromycin API in the Indian subcontinent (Bangladesh, India, and Pakistan), though it was not specific about how it would accomplish this. When Tianyin started construction of the facility, the China market for antibiotics was larger than it is now. China’s crackdown on antibiotic use lowered domestic prospects for sales just at Tianyin was spending to increase production. In its Q3 (ended March 30, 2013), Tianyin announced antibiotics produced $1.1 million in revenue. More details....

Stock Symbol: (NYSE: TPI)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital